Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Azapeptides as CD36 binding compounds

Azapeptides as CD36 binding compounds

US Patent 8435954 · Granted May 7, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cyclic peptides and uses thereof2024
Cyclic peptides and uses thereof2024
Lebecetin, a C-type lectin, as neovascularization inhibitor2021
Agents that activate CD47 and their use in the treatment of inflammation2021
Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof2021
Amide derivatives of polycaffeoylquinic acids, process for producing same and us2020
Agents for use in the treatment of retinal inflammation2019
Glycol esters of dicaffeoylquinic acid and uses thereof2019
CCR2 antagonist peptides2019
Azapeptides as CD36 binding compounds2017
Azapeptides as CD36 binding compounds2017
Azapeptides as CD36 binding compounds2017